ArticleNeuroradiology2025
Reproducible meningioma grading across multi-center MRI protocols via hybrid radiomic and deep learning features.
Article in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Are AI Neuroimaging Models Ready for Clinical Use? A Systematic Methodological Review.Journal of clinical medicine · 2026Review
- A scoping review of artificial intelligence applications in meningioma from image analysis to prognostic prediction.Discover oncology · 2026Review
- MRI Reflects Meningioma Biology and Molecular Risk.Cancers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to create a reliable method for preoperative grading of meningiomas by combining radiomic features and deep learning-based features extracted using a 3D autoencoder. The goal was to utilize the strengths of both handcrafted radiomic features and deep learning features to improve accuracy and reproducibility across different MRI protocols. MATERIALS AND
methodsThe study included 3,523 patients with histologically confirmed meningiomas, consisting of 1,900 low-grade (Grade I) and 1,623 high-grade (Grades II and III) cases. Radiomic features were extracted from T1-contrast-enhanced and T2-weighted MRI scans using the Standardized Environment for Radiomics Analysis (SERA). Deep learning features were obtained from the bottleneck layer of a 3D autoencoder integrated with attention mechanisms. Feature selection was performed using Principal Component Analysis (PCA) and Analysis of Variance (ANOVA). Classification was done using machine learning models like XGBoost, CatBoost, and stacking ensembles. Reproducibility was evaluated using the Intraclass Correlation Coefficient (ICC), and batch effects were harmonized with the ComBat method. Performance was assessed based on accuracy, sensitivity, and the area under the receiver operating characteristic curve (AUC).
resultsFor T1-contrast-enhanced images, combining radiomic and deep learning features provided the highest AUC of 95.85% and accuracy of 95.18%, outperforming models using either feature type alone. T2-weighted images showed slightly lower performance, with the best AUC of 94.12% and accuracy of 93.14%. Deep learning features performed better than radiomic features alone, demonstrating their strength in capturing complex spatial patterns. The end-to-end 3D autoencoder with T1-contrast images achieved an AUC of 92.15%, accuracy of 91.14%, and sensitivity of 92.48%, surpassing T2-weighted imaging models. Reproducibility analysis showed high reliability (ICC > 0.75) for 127 out of 215 features, ensuring consistent performance across multi-center datasets.
conclusionsThe proposed framework effectively integrates radiomic and deep learning features to provide a robust, non-invasive, and reproducible approach for meningioma grading. Future research should validate this framework in real-world clinical settings and explore adding clinical parameters to enhance its prognostic value.
Indexed as
Identifiers
40824403What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.